CD44 Overview
Molecule Name
CD44 antigen
Synonyms
CD44,CDW44,CSPG8,ECMR-III,HCELL,HUTCH-I,IN,LHR,MC56,MDU2,MDU3,MIC4,Pgp1,Epican
Drug Development Progress
Drugs in Clinical Trials10
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
Hermes Antigen，Hyaluronate Receptor，Cell Surface Glycoprotein CD44，MC56，PGP-1，CD44，CDW44，GP90 Lymphocyte Homing/Adhesion Receptor，MIC4，LHR，Hematopoietic Cell E- And L-Selectin Ligand，CD44 Antigen (Homing Function And Indian Blood Group System)，MDU3，Extracellular Matrix Receptor III，Heparan Sulfate Proteoglycan，HUTCH-I，ECMR-III，Epican，Chondroitin Sulfate Proteoglycan 8，Soluble CD44，MDU2，Pgp1，CSPG8，HCELL，Phagocytic Glycoprotein 1，Indian Blood Group Antigen，IN，Phagocytic Glycoprotein I，CD44 Molecule (Indian Blood Group)，CD44 Antigen，PGP-I，Homing Function And Indian Blood Group System，Hyaluronan Receptors，CD44R
CD44 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Paclitaxel/Hyaluronic acid | Phase 3 Clinical | Fidia Pharma | Carcinoma, Papillary; Urinary Bladder Neoplasms | Details | |
| CA-102N | CA-102N | Phase 2 Clinical | Holy Stone Healthcare Co Ltd | Colorectal Neoplasms; Solid tumours | Details |
| P-134 | P-134; P134 | Phase 2 Clinical | Tianjin Tasly Pharmaceutical Co Ltd | Glioblastoma | Details |
| Rosuvastatin liposome encapsulated therapy (Beijing Inno Medicine) | YN001; YN-001 | Phase 2 Clinical | Beijing Inno Medicine Co Ltd | Atherosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Erectile Dysfunction | Details |
| AMT-116(Multitude Therapeutics) | AMT-116; AMT-116-ADC | Phase 2 Clinical | Multitude Therapeutics Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Head and Neck Neoplasms; Solid tumours | Details |
| Hyaluronic acid/Fluorouracil | HA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complex | Phase 2 Clinical | Alchemia Ltd, Monash University | Colorectal Neoplasms | Details |
| AMC-303 | AMC-303; HP-558 | Phase 1 Clinical | Amcure Gmbh | Esophageal Squamous Cell Carcinoma; Solid tumours | Details |
| Clodronic acid/Hyaluronic acid | Phase 1 Clinical | Abiogen Pharma Spa | Osteoarthritis | Details | |
| 177Lu-AKIR001 | 177Lu-AKIR001 | Phase 1 Clinical | Akiram Therapeutics AB | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Thyroid Carcinoma, Anaplastic; Uterine Cervical Neoplasms; Vulvar Neoplasms | Details |
| BGC-0228 | BGC-0228 | Phase 1 Clinical | Brightgene Bio-Medical Technology Co Ltd | Solid tumours | Details |